Mobile Menu - OpenMobile Menu - Closed

Congressman Roger Marshall

Representing the 1st District of Kansas

Rep. Marshall co-hosts health care roundtable

November 16, 2018
Press Release

WASHINGTON D.C.- Congressman Roger Marshall, M.D. and Congressman Neal Dunn, M.D. hosted a roundtable this week to discuss the ways basic research supported by federal agencies can be used to improve and drive innovation within the medical community.

A key speaker at the roundtable was Dr. Scott Weir, the Director of the Institute for Advancing Medical Innovation at the University of Kansas. Dr. Weir shared the advances in cancer treatment KU is bringing to the medical community. 

Testimony provided by the panelists demonstrated that in order to realize patient benefit of federally-funded research, a multidisciplinary team effort involving basic, translational and clinical science experts is required,” Dr. Weir said following the roundtable. “Training the next generation of researchers who excel in transdisciplinary collaboration is critically important to improving human and animal health.”

Eight experts in fields varying from nuclear security to pharmacy industry leaders participated in the discussion held by the Science, Space, and Technology Committee.

“It was an honor to advocate for basic science research funding on behalf of the orthopedic community,” said Martha Murray, M.D., member of the American Association of Orthopedic Surgeons. “Federal grant funding makes possible the critical innovations we need for our growing patient population.” Dr. Murray discussed her background as an engineer and physician researcher and how she has applied basic science to ACL repairs, improving patient outcomes, recovering, and costs.

The roundtable focused on new opportunities for basic science research to improve care and lower health care costs, including ways the pharmacy industry can work to ensure these medical innovations are accessible to all, in both rural and urban America.

Dr. Troy Trygstad, a community pharmacist, health economist, and researcher, discussed how the pharmacy industry must utilize interdisciplinary research to optimize patient outcomes. "Interdisciplinary efforts are now widely recognized as catalyzing innovation and improving productivity,” Dr. Trygstad said. “To bring together NSF, the DOE and leaders from diverse foundational sciences together with downstream, frontline health care providers to discuss a framework for addressing our biggest health care challenges is both refreshing as well as forward thinking. I was so impressed to see eleven Members fully engaged in the conversation."

The roundtable was well attended, with nearly a dozen bipartisan members joining Rep. Marshall, M.D. and Rep. Dunn, M.D. to learn more about the benefits of this research.

It was an honor to sit alongside these brilliant minds and discuss ways that we can work together to improve health care outcomes and cut costs. The medical industry has come a long way thanks to technology and research, and it’s exciting to see the continual advances being made,” Congressman Marshall said.“ Science and research investments play a key role in delivering advancements for the next generation. I look forward to seeing the future success of projects like those discussed today and remaining a champion of research funding.”

From the ability to image proteins associated with Alzheimer’s disease to improved procedures in ACL repair, basic science plays a huge role in advancing medicine that is improving outcomes for patients across the country.